Released: September 13, 2019 Expires: February 28, 2021
CE for this activity will not be available after this date.
Conference Level: ProficientOverview This presentation will discuss the difference between difficult to treat versus resistant hypertension (HTN). The latest guidelines for treating HTN in adults will also be reviewed. Management of difficult to treat and resistant HTN will be discussed in the context of patient cases. An algorithm will be included in the handouts for use in clinical practice.
This CE activity is a recording of a CE session from the AANP 2019 National Conference. It has been edited to meet the requirements for online learning. If you received CE credit for attending the live session at Conference, you many not receive duplicate credit for this same activity in a different format.CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the educational content completely:
Video Presentations: Watch all video presentations completely.
Review all additional materials provided (handouts, posttest reviews, any other downloadable resources).
After completing all content, go to Steps to Receive Credit:
Complete the posttest
Submit the evaluation to receive full AANP CE/Rx credit.
Discuss the diagnosis and management of resistant hypertension (HTN) in adults.
Review how the 2017 treatment guidelines fit with the diagnosis of resistant HTN.
Identify which pharmacologic agents are indicated for add-on therapy after the first-line treatments have been prescribed.
Apply knowledge to case scenarios with difficult-to-treat and resistant HTN.
Speaker Leslie Davis, PhD, ANP-BC, FAANPDisclosure This program was planned in accordance with AANP CE Standards and Policies. Dr. Davis has no relevant affiliations to disclose.
Financially supported by the Transforming Clinical Practice Initiative (TCPi) grant, a Center for Medicare & Medicaid Services (CMS) award that provides free continuing education on topics related to patient & family-centered care, data-driven quality improvement and sustainable business operations.
This educational activity may contain opinions of the authors from their personal experience. The activity may contain discussion of published and/ or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/ participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.Additional Information For questions or more information concerning this online CE opportunity contact the AANP CE Center Manager at CECenter@aanp.org.
1 Contact Hour(s) of CE, All of which may be applied towards Pharmacology
Additional CE activities of interest
(OnDemand) The Essentials: Managing Hypertension in Primary Care
(OnDemand) Antimicrobial Therapy: Best Practice
(OnDemand) Pharmacology 101: What's New in the World Pharmacology
(OnDemand) Treatment of Hypertension in Older Adults: An Evidence-Based Approach
(OnDemand) Influenza Update and Review
(OnDemand) Understanding Asthma-COPD Overlap
(OnDemand) Managing Heart Failure: Clinical Pearls for Nurse Practitioners 2018
(OnDemand) Reducing Diagnostic Errors in Practice: A Call to Action for Nurse Practitioners
(OnDemand) 2019 Contraceptive Update
(Multi-Module) Introductory Certificate of Obesity Management in Primary Care (Modules 1-7)
(OnDemand) Venous Thromboembolism: Current Recommendations for Evaluating and Management in the Primary Care Setting